Compare AU
Compare IHD vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P/ASX Aussie Dividend Opportunities (IHD) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IHD | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 27 | 10 |
Median incremental investment | $644.56 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,350.56 | $624.97 |
Average age group | > 35 | > 35 |
Key Summary
IHD | EDOC | |
|---|---|---|
Strategy | IHD.AX was created on 2010-12-06 by iShares. The fund's investment portfolio concentrates primarily on high dividend yield equity. The ETF currently has 305.98m in AUM and 51 holdings. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of 50 ASX listed stocks that offer high dividend yields while meeting diversification, profitability and tradability requirements as well as being screened for sustainability considerations | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | RIO TINTO LTD (9.87 %) FORTESCUE LTD (8.72 %) WESTPAC BANKING CORPORATION CORP (8.18 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Financials (42.51 %) Materials (22.84 %) Industrials (13.44 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | Australia (99.25 %) New Zealand (0.75 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.23 % | 0.67 % |
Key Summary
IHD | EDOC | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | S&P/ASX Dividend Opportunities Index - AUD | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.23 % | 0.67 % |
Price | $14.68 | $10.33 |
Size | $313.421 million | $1.525 million |
10Y return | 3.89 % | N/A |
Annual distribution yield (5Y) | 7.42 % | - % |
Market | ASX | ASX |
First listed date | 09/12/2010 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IHD | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 27 | 10 |
Median incremental investment | $644.56 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,350.56 | $624.97 |
Average age group | > 35 | > 35 |
Pros and Cons
IHD | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IHD | EDOC |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |